Literature DB >> 17350375

Relation of family history of myocardial infarction and the presence of coronary arterial calcium in various age and risk factor groups.

Binu Philips1, James A de Lemos, Mahesh J Patel, Darren K McGuire, Amit Khera.   

Abstract

Family history of myocardial infarction (FHMI) is an independent risk factor for cardiovascular (CV) events but may be more informative in certain subgroups. The association between FHMI and the presence of coronary artery calcium (CAC) was examined in various age and risk factor groups in the Dallas Heart Study (DHS), a population-based probability sample of subjects aged 30 to 65 years. Analyses were stratified by age (with the young group composed of men aged <45 years and women aged <55 years) and by the presence of 0, 1, 2, or >2 CV risk factors. In the overall cohort of 2,743 subjects, FHMI was an independent predictor of CAC (adjusted odds ratio 1.3, 95% confidence interval 1.1 to 1.7), attributable to an independent association between FHMI and CAC in the young group (adjusted odds ratio 1.5, 95% confidence interval 1.0 to 2.1) that was not evident in the older subset (adjusted odds ratio 1.2, 95% confidence interval 0.91 to 1.6, interaction p = 0.02). In the young cohort, the association between FHMI and CAC was particularly robust in those with > or = 2 risk factors (FHMI-by-risk factor interaction p = 0.04). In older subjects, FHMI was not associated with CAC for any risk factor category (p >0.05 for each). In conclusion, this study suggests that FHMI is a more important predictor of atherosclerosis in young compared with older adults and, among the young, in those with multiple CV risk factors.

Entities:  

Mesh:

Year:  2007        PMID: 17350375     DOI: 10.1016/j.amjcard.2006.10.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.

Authors:  Purav Mody; Parag H Joshi; Amit Khera; Colby R Ayers; Anand Rohatgi
Journal:  J Am Coll Cardiol       Date:  2016-05-31       Impact factor: 24.094

2.  Family history of coronary heart disease and the incidence and progression of coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Arvind K Pandey; Michael J Blaha; Kavita Sharma; Juan Rivera; Matthew J Budoff; Ron Blankstein; Mouaz Al-Mallah; Nathan D Wong; Leslee Shaw; Jeffery Carr; Daniel O'Leary; Joao A C Lima; Moyses Szklo; Roger S Blumenthal; Khurram Nasir
Journal:  Atherosclerosis       Date:  2013-12-06       Impact factor: 5.162

3.  Coronary artery calcium findings in asymptomatic subjects with family history of premature coronary artery disease.

Authors:  Catalin Taraboanta; Cameron J Hague; G B John Mancini; Bruce B Forster; Jiri Frohlich
Journal:  BMC Cardiovasc Disord       Date:  2012-07-17       Impact factor: 2.298

4.  Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients.

Authors:  Rona Reibis; Andras Treszl; Karl Wegscheider; Kurt Bestehorn; Barbara Karmann; Heinz Völler
Journal:  Vasc Health Risk Manag       Date:  2012-08-17

5.  Demographics and Angiographic Findings in Patients under 35 Years of Age with Acute ST Elevation Myocardial Infarction.

Authors:  Seyed Kianoosh Hosseini; Abbas Soleimani; Mojtaba Salarifar; Hamidreza Pourhoseini; Ebrahim Nematipoor; Seyed Hesameddin Abbasi; Ali Abbasi
Journal:  J Tehran Heart Cent       Date:  2011-05-31

6.  Premature Parental Cardiovascular Disease and Subclinical Disease Burden in the Offspring.

Authors:  Wolfgang Lieb; Rebecca J Song; Ramachandran S Vasan; Vanessa Xanthakis
Journal:  J Am Heart Assoc       Date:  2020-09-08       Impact factor: 5.501

7.  Identification and treatment of those most at risk for premature atherosclerotic cardiovascular disease: We just cannot seem to get it right.

Authors:  Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2020-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.